Publications

Pubmed logo      Google Scholar

Select Publications

  1. Krishna S, Anderson KS.T-Cell Epitope Discovery for Therapeutic Cancer Vaccines. Methods Mol Biol. 2016;1403:779-96. doi: 10.1007/978-1-4939-3387-7_45.

  2. Ewaisha R, Anderson KSProteomic Monitoring of B Cell Immunity. Methods Mol Biol. 2016;1403:131-52. doi: 10.1007/978-1-4939-3387-7_6.

  3. Chowell D, Krishna S, Becker P, Cocita, Cocita, C, Shu J, Tan X, Greenberg P, Klavinskis L, Blattman J, Anderson KS.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes, PNAS 2015: 1500973112v1-21500973. http://www.pnas.org/content/early/2015/03/20/1500973112.abstract

  4. Chowell D, Castillo-Chavez C, Krishna S, Qiu X, Anderson KS. Modelling the effect of early detection of Ebola, Lancet Infect Dis. 2015 Feb; 15(2): 148-49.

  5. Ferdosi, Shayesteh R., and Ewaisha, Radwa and Moghadam, Farzaneh and Krishna, Sri and Park, Jin G and Ebrahimkhani, Mo R and Kiani, Samira and Anderson, Karen S. “Multifunctional CRISPR-Cas9 with Engineered Immunosilenced Human T Cell Epitopes.” Nature Communications, vol. 10, no. 1, 2019, doi:10.1038/s41467-019-09693-x.

  6. Campos-Romero, Abraham, and Anderson, Karen S and Longatto-Filho, Adhemar and Esparza, Marco A Luna-Ruiz and Moran-Portela, David J and Castro-Menendez, Javier A and Moreno-Camacho, Jose L and Calva-Espinosa, Diana Y and Acosta-Alfaro, Manuel A and Meynard-Mejia, Freddy A and others “The Burden of 14 Hr-HPV Genotypes in Women Attending Routine Cervical Cancer Screening in 20 States of Mexico: a Cross-Sectional Study.” Scientific Reports, vol. 9, no. 1, 2019, doi:10.1038/s41598-019-46543-8.

  7. McDonald BR, Contente-Cuomo T, Sammut SJ, Ernst B, Odenheimer-Bergman A, Perdigones N, Chin SF, Farooq M, Cronin PA, Anderson KS, Kosiorek H, Northfelt D, McCullough A, Patel B, Weitzel J, Slavin T, Caldas C, Pockaj B, Murtaza,M. “Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.” Poster Session Abstracts, 2019, doi:10.1158/1538-7445.sabcs18-p4-01-21.

  8. Krishna S, Ulrich P, Wilson E, Parikh F, Narang P, Yang S, Read AK, Kim-Schulze S, Park JG, Posner M, Sayres MA, Sikora A, Anderson KS. Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer. Cancer research. 2018 Nov; 78 (21): 6159-6170. doi: 10.1158/0008-5472

  9. Wilson EA, Anderson KS. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy. Expert Review of Proteomics. 2018 Dec; 15 (12):1065-1077. https://doi.org/10.1080/14789450.2018.1545578 


2019

  1. Ferdosi, Shayesteh R., and Ewaisha, Radwa and Moghadam, Farzaneh and Krishna, Sri and Park, Jin G and Ebrahimkhani, Mo R and Kiani, Samira and Anderson, Karen S. “Multifunctional CRISPR-Cas9 with Engineered Immunosilenced Human T Cell Epitopes.” Nature Communications, vol. 10, no. 1, 2019, doi:10.1038/s41467-019-09693-x.

  2. Campos-Romero, Abraham, and Anderson, Karen S and Longatto-Filho, Adhemar and Esparza, Marco A Luna-Ruiz and Moran-Portela, David J and Castro-Menendez, Javier A and Moreno-Camacho, Jose L and Calva-Espinosa, Diana Y and Acosta-Alfaro, Manuel A and Meynard-Mejia, Freddy A and others “The Burden of 14 Hr-HPV Genotypes in Women Attending Routine Cervical Cancer Screening in 20 States of Mexico: a Cross-Sectional Study.” Scientific Reports, vol. 9, no. 1, 2019, doi:10.1038/s41598-019-46543-8.

  3. McDonald BR, Contente-Cuomo T, Sammut SJ, Ernst B, Odenheimer-Bergman A, Perdigones N, Chin SF, Farooq M, Cronin PA, Anderson KS, Kosiorek H, Northfelt D, McCullough A, Patel B, Weitzel J, Slavin T, Caldas C, Pockaj B, Murtaza,M. “Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.” Poster Session Abstracts, 2019, doi:10.1158/1538-7445.sabcs18-p4-01-21.


2018

  1. Ferdosi S, Rehder DS, Maranian P, Castle EP, Ho TH, Pass HI, Cramer DW, Anderson KS, Fu L, Cole DEC, Le T, Wu X, Borges CR. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and a2-6 Sialylation in Cancer. J Proteome Res.2018 Jan 5;17(1):543-558. PMID: 29129073

  2. Race CM, Kwon LE, Foreman MT, Huang Q, Inan H, Kesiraju S, Le P, Lim SJ, Smith AM, Zangar RC, Demirci U, Anderson KS, Cunningham BT. An Automated Microfluidic Assay for Photonic Crystal Enhanced Detection and Analysis of an Antiviral Antibody Cancer Biomarker in Serum. IEEE Sens J. 2018 Feb 15; 18(4):1464-1473. PMID: 29881332

  3. Kaaks R, Fortner RT, Hüsing A, Barrdahl M, Hopper M, Johnson T, Tjønneland A, Hansen L, Overvad K, Fournier A, Boutron-Ruault MC, Kvaskoff M, Dossus L, Johansson M, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Sieri S, Mattiello A, Palli D, Tumino R, Matullo G, Onland-Moret NC, Gram IT, Weiderpass E, Sánchez MJ, Navarro Sanchez C, Duell EJ, Ardanaz E, Larranaga N, Lundin E, Idahl A, Jirström K, Nodin B, Travis RC, Riboli E, Merritt M, Aune D, Terry K, Cramer DW, Anderson KS. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation. Int J Cancer, 2018 Feb 22. PMID: 29473162

  4. Anderson KS. Mork J, Langseth H, Wallstrom G. Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodologic issues. Oral Oncol. 2018 May. PMID: 29606498.

  5. Henderson MC, Silver MS, Tran Q, Letsios E, Mulpuri R, Reese DE, Lourenco AP, LaBaer J, Anderson KS, Hollingsworth A, Alpers J, Costantini C, Peterson H, Rohatgi N, Haythem A, Baker K, Northfelt D, Ghosh K, Grobmyer S, Polen W, Wolf J. A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Post-Menopausal Women with BI-RADS 3, 4, or 5 Assessment. Clin Cancer Res. 2018 Sep 5. pii: clincanres.0843.2018. PMID: 30185421

  6. Obahiagbon U, Smith JT, Zhu M, Katchman BA, Arafa H, Anderson KS, Blain Christian JM. A Compact, Low-cost, Quantitative and Multiplexed Fluorescence Detection Platform for Point-of-Care Applications. Biosensors and Bioelectronics. 2018 Oct 15;117:153-160. PMID: 29894852

  7. Chen M, Andreozzi M, Pockaj B, Barrett MT, Krishna S, Eaton S, Niu R, Anderson KS. JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer. Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780-2. PMID: 29933930

  8. Katchman B, Zhu M, Blain Christen J, Anderson KS. Eccrine Sweat as a Biofluid for Profiling Immune Biomarkers. In press, Proteomics Clinical Applications. Proteomics-Clinical Applications. 2018 June 8. https://doi.org/10.1002/prca.201800010

  9. Spanias A. Blain Christen J, Thornton T, Anderson KS, Goryll M, Arafa H, Shanthamallu U, Forzani E, Ross H, Barnard W, Ozev S. "The Sensor Signal and Information Processing REU Site, " Proc. 2018 ASEE Annual Conference, Salt Lake City, Utah, June 2018.

  10. Ferdosi SR, Ewaisha R, Moghadam F, Krishna S, Park JG, Ebrahimkhani MR, Kiani S, Anderson KS. Multifunctional CRISPR/Cas9 with engineered immunosilenced human T cell epitopes. bioRxiv. 2018 July 2. https://doi.org/10.1101/360198

  11. Barrett MT, Lenkiewicz E, Malasi S, Basu A, Yearley JH, Annamalai L, McCullough AE, Kosiorek HE, Narang P, Wilson Sayres MA, Chen M, Anderson KS, Pockaj BA. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers. Breast Cancer Res. 2018 Jul 11;20(1):71. PMID: 29996881

  12. Krishna S, Ulrich P, Wilson E, Parikh F, Narang P, Yang S, Read AK, Kim-Schulze S, Park JG, Posner M, Sayres MA, Sikora A, Anderson KS. Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer. Cancer research. 2018 Nov; 78 (21): 6159-6170. doi: 10.1158/0008-5472

  13. Wilson EA, Anderson KS. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy. Expert Review of Proteomics. 2018 Dec; 15 (12):1065-1077. https://doi.org/10.1080/14789450.2018.1545578 


2017

  1. Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W,m Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ. NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res. 2017 Mar 7. PMID: 28270497

  2. Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Autoantibody biomarkers for the detection of serous ovarian cancer. Gynecol Oncol. 2017 Apr 17. Pii: S0090-8258(17)30775-8 doi: 10.1016/j.yfyno.2017.04.005. PMID: 28427776.

  3. Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Couskos G. A phase 2, randomized, double-bind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol. 2017 May 1. 28(5):996-1004. Doi: 10.1093/annonc/mdx049.

  4. Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD. Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma. Cancer Biomarker 2017;19(2):129-136. PMID: 28387659.

  5. Anderson KS, Wallstrom G, Langseth H, Posner M, Cheng JN, Alam R, Chowell D, Furre IE, Mork J. Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer. Oral Oncology 2017 Oct. 2017 Sep 1. PMID: 28939065. 

  6. Chen M, Andreozzi M, Pockaj B, Barrett MT, Ocal IT, McCullough AE, Linnaus ME, Chang JM, Yearley JH, Annamalai L, Anderson KS. Development and Validation of a Novel Clinical Fluorescence in Situ Hybridization Assay to Detect JAK2 and PD-L1 amplification. Modern Pathology. 2017 Nov;30(11):1516-1526.PMID: 28752839.

  7. Inan H, Wang S, Inci F, Baday M, Zangar R, Kesiraju S, Anderson KS, Cunningham BT, Demirci U. Isolation,  Detection, and Quantification of Cancer Biomarkers in HPV-Associated Malignancies.  Sci Rep. 2017 Jun 12;7(1):3322. PMID: 28607383.

  8. Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan Y, Pienta KJ, Anderson KS, Gatenby R, Swanton C, Posada D, Wu CI, Schiffman JD, Hwang ES, Polyak K, Anderson ARA, Brown JS, Greaves M, Shibata D. Classifying the Evolutionary and Ecological Features of Neoplasms. Nature Reviews Cancer. 2017 Oct;17(10):605-619. PMID: 28912577.

  9. Chang JM, Kosiorek HE, Wasif N, Gray RJ, Stucky CH, Northfelt DW, Anderson KS, McCullough AE, Tolgay Ocal I,Pockaj BA. Discussion of: “The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review”. Am J Surg. 2017 Dec;214(6):1102-1103. PMID: 29037421.

  10. Ewaisha R, Panicker G, Maranian P, Unger R, Anderson KS. Serum Immune Profiling for Early Detection of Cervical Disease. Theranostics. 2017 Aug 23;7(16):3814-3823. PMID: 29109779 

  11. Chowell D, Napier J, Gupta R, Anderson KS, Maley CC, Wilson Sayres MA. Modeling the subclonal evolution of cancer cell populations. Cancer Res. 2017 Nov 29. PMID: 29187407

  12. Dahlstrom KR, Anderson KS, Field MS, Chowell D, Ning J, Li N, Wei Q,Li G, Sturgis EM. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15;123(24):4886-4894. PMID: 28898394


2016

  1. *Ewaisha R, °Meshay I, °Resnik J, **Katchman BA, and Anderson KS. Programmable protein 
    arrays for immunoprofiling HPV-associated cancers, Proteomics. 2016 Apr;16(8):1215-24. doi: 10.1002/pmic.201500376. Epub 2016 Apr 7. PMID: 27089055

  2. **Katchman BA, Barderas R, °Alam R, #Chowell D, #Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer DW, Hollingsworth MA, Anderson KS. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers. Proteomics Clin Appl. 2016 Jul;10(7):720-31. doi: 10.1002/prca.201500096. Epub 2016 May 17. PMID: 27121307   

  3. **Katchman BA, Smith JT, Obahiagbon U, **Kesiraju S, Lee YK, O’Brien B, Kaftanoglu K, Blain Christen J, Anderson KS. Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkers. Sci Rep. 2016 Jul 4;6:29057. doi: 10.1038/srep29057. PMID: 27374875   

  4. Dahlstrom KR, Anderson KS, Sturgis EM. Human Papillomavirus-Associated Oropharyngeal Cancer: Not Just White Men Anymore. JAMA Oncol. 2016 Dec 8. doi:10.1001/jamaoncol.2016.3510 PMID: 27930755                                                        


2015

  1. #Chowell D, Castillo-Chavez C, #Krishna S, Qiu X, Anderson KS. Modelling the effect of early detection of Ebola. Lancet Infect Dis. 2015 Feb;15(2):148-49. doi: 10.1016/S1473-3099(14)71084-9. Epub 2015 Jan 19. PMID: 25749063 

  2. #Chowell D, #Krishna S, Becker PD, Cocita, C, Shu J, Tan X, Greenberg PD, Klavinskis LS, Blattman JN, Anderson KS.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes. Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1754-62.doi: 10.1073/pnas.1500973112. Epub 2015 Mar 23. PMID: 25831525; PMCID: PMC4394253

  3. Anderson KS, Dahlstrom KR, Cheng JN, °Alam R, Li G, Wei Q, Gross ND, #Chowell D, Posner M, Sturgis EM. HPV 16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Oral Oncol. 2015 Jul;51(7):662-7. doi: 10.1016/j.oraloncology.2015.04.011. Epub 2015 May 6. PMID: 25957822; PMCID: PMC4457560

  4. Chang JM, McCullough AE, Dueck AC, Kosiorek HE, Ocal IT, Lidner TK, Gray RJ, Wasif N, Northfelt DW, Anderson KS, Pockaj BA. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma. Ann Surg Oncol. 2015 Dec;22 Suppl 3:509-15. doi: 10.1245/s10434-015-4616-y. Epub 2015 May 22.  PMID: 26001860 

  5. Wang J, Figueroa JD, Wallstrom G, Barker K, Park JG, Demirkan G, Lissowska J, Anderson KS, Qiu J, LaBaer J. Plasma Autoantibodies Associated with Basal-like Breast Cancers. Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1332-40. doi: 10.1158/1055-9965.EPI-15-0047. Epub 2015 Jun12. PMID: 26070530 

  6. Dahlstrom KR, Anderson KS, Cheng JN, #Chowell D, Li G, Posner M, Sturgis EM. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clin Cancer Res. 2015 Jun 15;21(12):2861-9, doi: 10.1158/1078-0432.CCR-14-3323. PMID: 26078432 

  7. Anderson KS, Gerber JE, D’Souza G, Pai SI, Cheng JN, °Alam R, **Kesiraju S, #Chowell D, Gross ND, Haddad R, Gillison ML, Posner M. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Oral Oncol. 2015 Aug;51(8):751-8. doi: 10.1016/j.oraloncology.2015.05.007.  Epub 2015 Jun 18. PMID: 26094591 

  8. Barrett MT, Anderson KS, Lenkiewicz E, Andreozzii M, Cunliffe HE, Klassen CL, Dueck AC, McCullough AE, Reddy SK, Ramanathan RK, Northfelt DW, Pockaj BA. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer. Oncotarget 2015 Sep 22;6(28):26483-93. doi: 10.18632/oncotarget.4494 PMID: 26317899

  9. Linnaus ME, Dueck AC, Kosiorek HE, Gray RJ, Wasif N, Northfelt DW, Anderson KS, McCullough AE, Wong WW, Halyard MY, Patel SH, Pockaj BA. Regional recurrence in the era of sentinel lymph node biopsy. Am J Surg. 2015 Dec;210(6):1155-61. doi:10.1016/j.amjsurg.2015.09.001. Epub 2015 Sep 28. PMID: 26601646

  10. Smith JT, **Katchman BA, Kullman DE, Obahiagbon U, Lee YK, O’Brien BP, Raupp GB, Anderson KS, Blain Christen J. Application of Flexible OLED Display Technology to Point-of-Care Medical Diagnostic Testing. IEEE/OSA Journal of Display Technology. Sep 2015


2014

  1. Marks Jr, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease, Cancer Epidemiol Biomarkers Prev.2014 Dec 3; 24(2);1-7.

  2. Anderson KS, Cramer DW, Sibani S, Wallstrom G, Wong J, Park J, Qiu J, Vitonis A, LaBaer J. An autoantibody signature for the serologic detection of ovarian cancer, Journal Proteome Research. 2014 Nov 3:578-586 PMID 25365139

  3. Zeng W, Su M, Anderson KS, Sasada T, Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens, Immunobiology. 2014 Aug;219(8):583-92. doi: 10.1016/j.imbio.2014.03.003. Epub 2014 Mar 20.  PMID: 24713579

  4. D’Souza G, Gross N, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber J, Gillison ML, Posner M. Oral human papillomavirus (HPV)-positive oropharyngeal cancer cases and their partners. Journal of Clinical Oncology. 2014 Apr 28. 55.1341. PMID: 24778397.

  5. Siufi Neto J, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):55-63. doi: 10.1016/j.jmig.2013.07.021. Epub 2013 Aug 17. Review. PMID: 23962574 Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.

  6. Johnson DH, Khanna S, Smyrk TC, Loftus EV Jr, Anderson KS, Mahoney DW, Ahlquist DA, Kisiel JB. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn’s colitis. Aliment Pharmacol Ther. 2014 Jun. 39(12)1408-17. PMID: 24779703. doi: 10.1111/apt.12774


2013

  1. Wallstrom G, Anderson KS, LaBaer J. Biomarker Discovery for Heterogeneous Diseases, Cancer Epidemiology, Biomarkers & Prevention. 2013 May;22(5):747-755. PMID: 23462916

  2. Wang J, Barker K, Steel J, Park J, Saul J, Festa F, Wallstrom G, Yu X, Bian X, Anderson KS, Figueroa JD, LaBaer J, Qiu J. Proteomics Clin Appl. 2013 Jun;7(5-6):378-83. doi: 10.1002/prca.201200062. Epub 2013 May 17. A versatile protein microarray platform enabling antibody profiling against denatured proteins.


2011

  1. Anderson KS. Multiplexed Detection of Antibodies using Programmable Bead Arrays. Methods Mol. Biol. 2011, 723:227-38.

  2. Yang C, Hayashida T, Li C, Shen D, Maheswaren S, Chen L, Anderson KS, Sgroi DC,and Schmidt EV.  Dual roles of the integrin αvβ3-5 ligand MFG-E8: Suppressive functions in ER+ and erbB2+ breast cancer and p63/73 target gene in triple negative breast cancers. Cancer Research 2011, 71(3):937-45

  3. Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K. J Clin Invest. The JAK2/STAT3 signaling pathway is required for growth of CD44CD24 stem cell-like breast cancer cells in human tumors. 2011 Jul;121(7):2723-35. doi: 10.1172/JCI44745.

  4. Chen J, Yu F, Gong C, Yao Y, Deng H, Wang F, Lin L, Su S, Yao H, Su F, Anderson KS, Liu Q, Ewen ME, Yao X, and Song E.  CCL18 from tumor associated macrophages promotes epithelial-mesenchymal transition and metastasis of breast cancer cells via PITPNM3. Cancer Cell, 2011  Apr 12;19(4):541-55.

  5. Anderson KS, Zeng W, Sasada T, Su M, Drakoulakos D, Kang Y-J, Brusic V, Wu C, and Reinherz EL.  Impaired Tumor Antigen Processing by Immunoproteasomes in CD40-Activated B cells and Dendritic Cells. Cancer Immunol. Immunother. 2011, 60: 857-67.

  6. Marotta L, Almendro V, Shipitsin M, Marusyk A, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA and Polyak K. Specific activation and requirement of Stat3 in CD44+CD24- breast cancer cells.  Journal of Clinical Investigation 2011, 121: 2723-35.

  7. Anderson KS, Wong J,  D’Souza G,  Riemer AB,  Lorch J,  Haddad R,  Pai S,  Longtine J,  Bryan J, McClean M, LaBaer J, Kelsey KT,  and Posner  M. Serum Antibodies to the HPV16 Proteome As Biomarkers For Head and Neck Cancer.  Brit. J. Cancer 2011, 104: 1896-905.

  8. Anderson KS,  Sibani S,  Wallstrom G, Qiu J,  Mendoza E, Raphael, J, Hainsworth E,  Montor W, Wong J,  Lokko N,  Ramachandran N,  Godwin A, Marks J, Engstrom P, and LaBaer J. A Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer. J. Proteome Res. 2011 Jan 7;10(1):85-96


2010

  1. Reimer A, Keskin D, Zhang G, Handley M, Anderson KS, Brusic V, Reinhold B, and Reinherz E. A conserved E7-derived CTL epitope expressed on human papillomavirus-16 transformed HLA-A2+ human epithelial cancers.  J.Biol.Chem. 2010. Sep 17;285(38):29608-22.

  2. Anderson KS, Wong J, Vitonis A, Crum CP, Sluss PM, LaBaer J, and Cramer D.  p53 Autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epi Biomark and Prev, 2010, Mar;19(3):859-68.

  3. Anderson KS, Petersson S, Wong J, Shubbar E, Lokko NN, and Enerback C. Elevation of serum epidermal growth factor  and IL-1 receptor antagonist  in active psoriasis vulgaris. Br J Dermatol. 2010 Nov;163(5):1085-9.


2009

  1. Wong J, Sibani S, Lokko NL, LaBaer J, and Anderson KS. Rapid Detection of Antibodies in Sera using Multiplexed Self-Assembling Bead Arrays.  J Immunol Methods 2009, Oct 31;350(1-2):171-82.

  2. Mirshahidi S, Kramer VG, Whitney JB, Essono S, Lee S, Anderson KS, Dranoff G,and Ruprecht RM. Reduced Tumor Growth and Prolong Survival after Immunization of Mice with Overlapping Synthetic Peptides Covering Tumor Protein D52.  Vaccine. 2009 Mar 13;27(12):1825-33.

  3. Anderson KS, Wong, J, Polyak K, Aronzon D, and Enerback, C.  Detection of Psoriasin/S100A7 in the Sera of Psoriatic Patients.  Br J Dermatol. 2009; Feb;160(2):325;32.


2008

  1. Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, Labaer J.Application of Protein Microarrays for Multiplexed Detection of Antibodies to Tumor Antigens in Breast Cancer. J Proteome Res. 2008 Apr 4;7(4):1490-1499.

  2. Ramachandran N*, Anderson KS*, Raphael JV, Hainsworth E, Sibani S, Montor W, Pacek M, Wong J, Eljanne M, Sanda MG, Hu Y, Logvinenko T, and Labaer J. Tracking Humoral Responses Using Self Assembling Protein Microarrays. Proteomics Clin. Appl. 2008, 2, 1518-1527